Keyphrases
Aberrations
17%
Anthracyclines
24%
BCL2 Translocation
16%
Colon Cancer
16%
Colorectal Cancer
33%
Colorectal Cancer Patients
17%
Copy number Variation
16%
DNA Topoisomerase
21%
Epirubicin
16%
Gene Amplification
17%
Gene Copy number
100%
Human Breast Cancer Cell Lines
16%
In Vitro Resistance
16%
Irinotecan
52%
Metastatic Colorectal Cancer (mCRC)
37%
Molecular Characterization
16%
MRNA Expression
16%
Number Expressions
18%
Objective Response
16%
Oxaliplatin Resistance
16%
Patients with Breast Cancer
18%
Pharmacodiagnostics
16%
Phase II Study
16%
Predictive Biomarker
37%
Repurposing
16%
SN-38
20%
Stage II-III
16%
Stage III Colorectal Cancer
17%
Topoisomerase
65%
Topoisomerase IIα
18%
Translocation Partner Genes
16%
α Gene
16%
Medicine and Dentistry
Anthracycline
21%
Biological Marker
35%
Colon Carcinoma
16%
Colorectal Carcinoma
16%
DNA Topoisomerase (ATP Hydrolysing)
18%
Epidermal Growth Factor Receptor 2
16%
Epirubicin
16%
Gamma Urogastrone
16%
Gene Amplification
16%
Gene Dosage
48%
Immunoreactivity
16%
Irinotecan
32%
Messenger RNA
16%
Metastatic Colorectal Cancer
35%
Oxaliplatin
21%
Topoisomerase
32%
Biochemistry, Genetics and Molecular Biology
ABCG2
16%
B Cell
16%
Cancer Cell
19%
DNA Topoisomerase
48%
Epidermal Growth Factor Receptor
16%
Epirubicin
16%
Gene Amplification
17%
Gene Dosage
36%
Immunoreactivity
16%
TOP1
18%
TOP2A
18%
Topoisomerase
48%
